Yeztugo

Gilead Sciences Yeztugo HIV PrEP
Manufacturing

Manufacturing is key to Gilead's Yeztugo PrEP rollout: exec

The company was baking process and scale-up considerations into Yeztugo R&D “from the beginning," Gilead manufacturing chief Stacey Ma told Fierce.
Fraiser Kansteiner Mar 13, 2026 10:33am
Gilead Sciences One2PrEP Yeztugo ad

'One2PrEP': Gilead's 1st Yeztugo ad highlights biannual dosing

Mar 2, 2026 3:39pm
Gilead

Gilead further pads case for single-tablet HIV med

Feb 25, 2026 1:50pm
Gilead

‘Pieces are coming together’ amid Gilead's Yeztugo launch: exec

Feb 11, 2026 11:34am
HIV AIDS PREP
Favicon Fierce Biotech

Study finds HIV can evolve to resist lenacapavir—at a cost

Jan 7, 2026 2:00pm
Gilead

Gilead's bictegravir, lenacapavir tablet meets mark in phase 3

Nov 13, 2025 9:55am